Advanced Research Tool
Harness the full power of data with the Implicity platform for clinical research
Company profile
Company profile
Implicity is a pioneer in SaaS agnostic platforms for cardiac implantable electronic device (CIED) remote monitoring, equipped with FDA-cleared AI-driven software as a medical device. The company's platform centralizes and standardizes all cardiac device data into one unified system, enabling healthcare providers to monitor patients more efficiently and make faster, more confident clinical decisions. The platform features AI-driven alert management that filters false positives, smart workflow automation for billing and reporting, and real-time access from anywhere. Implicity serves physicians, care teams, administrative staff, and IT teams across cardiology practices and health systems. The platform has demonstrated significant clinical impact, with studies showing a 26% reduction in mortality and 4% reduction in hospitalization length compared to conventional remote monitoring. Key product features include the ILR ECG Analyzer that reduces false positives by 79%, AF Alert Management that decreases unnecessary atrial fibrillation alerts by 85%, Patient Connectivity Management that reconnects 28% of disconnected patients within two days, and SignalHF predictive AI for heart failure hospitalization prediction. The company holds multiple FDA clearances and CE marks for its medical device software, and maintains certifications including HIPAA and SOC2 compliance. Implicity serves healthcare providers across the United States and Europe, with separate platforms for each region.
Company description Implicity official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Recorded integration context: EHR systems for billing and reporting, Medtronic ILRs, Multiple cardiac device manufacturers (device-agnostic platform).
Company milestones
Selected as official remote monitoring platform for DAI-PP2, one of the largest European research consortiums on ICDs with 5,000+ patients expected enrollment. Multiple customer implementations including Virginia Cardiovascular Consultants, Citizens Medical Center's Cardiovascular Associates of Victoria, and Cardio Vascular Health Clinic.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Harness the full power of data with the Implicity platform for clinical research
Detect clinically relevant events with 85% decrease in unnecessary AF alerts
Achieve 90%+ billing compliance with optimized scheduling and auto-generated reports
FDA-cleared AI reducing false positives by 79% when analyzing ECG recordings from Medtronic ILRs
AI-powered platform unifying all cardiac device data for faster decisions and efficient remote monitoring
Streamline your in-clinic data workflow for cardiac device management
Reconnect 28% of patients two days after they disconnect using automated SMS
FDA-cleared AI algorithm that predicts heart failure hospitalizations
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Therapie · Jan 1, 2026
[Not Available].Therapie · Jan 1, 2026
Impact of a universal monitoring system ("third party") on outcomes of ICD patients: A nationwide study.Heart rhythm · Oct 1, 2025
Using technology to improve reconnection to remote monitoring in cardiac implantable electronic device patients.Cardiovascular digital health journal · Feb 1, 2024
Observation of human-animal interaction for research (OHAIRE) behavior coding in a randomized control trial of children with attention-deficit hyperactivity disorder (ADHD) and a canine-assisted intervention.Frontiers in psychiatry · Jan 1, 2024
Improved diagnostic performance of insertable cardiac monitors by an artificial intelligence-based algorithm.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · Dec 28, 2023
Clinical validation
NCT07247032 · Sponsor · RECRUITING
The Effects of Listening to Fairy Tales, Listening to Fairy Tales in Their Mothers' Voices, and Watching Cartoons on Pain, Comfort Levels, and Physiological Parameters During Tracheostomy Care in a Palliative Care ClinicNCT07210346 · Mentioned · NOT YET RECRUITING
The Effect of Listening to Stories and Watching Cartoon Film on Pain in the Aspiration Process in Children Receiving Palliative CareNCT06010771 · Mentioned · COMPLETED
Regulatory
K230842 · 510k · Oct 25, 2023
IM007K210543 · 510k · Nov 3, 2021
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
compared to conventional remote monitoring in nationwide study
compared to conventional remote monitoring
when analyzing ECG recordings from Medtronic ILRs
for ILR ECG analysis
compared to alerts transmitted by CIED
within two days of disconnection using automated SMS
with optimized scheduling and auto-generated reports
Finding a consistent, efficient, and profitable solution for remote cardiac device monitoring while ensuring reliable patient monitoring and optimizing revenue
Significant revenue impact by capturing non-compliant patients and ensuring all missing reports and billable events are captured
Streamlining workflow for remote device monitoring by eliminating manual processes of switching between manufacturer portals, printing, and scanning reports
Immediate improvements in workflow efficiency, increased device capture and connectivity, significant time savings from paperless system
Managing cardiac rhythm management (CRM) devices, wearable cardiac devices, and heart failure devices for CIED patients
Official remote monitoring platform for one of the largest European research programs on ICDs with massive real-time follow-up of ICD patients
5,000+ patients expected to be enrolled during first two years; 1,400+ patients already enrolled across 17 French university hospitals and private clinics
Optimize patient management and anticipate complications by applying AI to remote cardiac monitoring
Utilizing FDA-cleared AI and sophisticated data delivery for remote cardiac monitoring
05 · Leadership
Leadership profiles and professional links from the current Company record.
Manish Wadhwa
MD
06 · Company updates
Recent articles published on Implicity's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.